Evidence map›Paper›PMID 30744100›Full record

ArticleInternational journal of molecular sciences2019

Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus.

Robin P F Dullaart, Sabrina Pagano, Frank G Perton, Nicolas Vuilleumier

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Robin P F DullaartDepartment of Endocrinology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. r.p.f.dullaart@umcg.nl.
Sabrina PaganoDivision of Laboratory Medicine, Department of Diagnostics, Hộpitaux Universitaires de Geneve, 1211 Geneva, Switzerland. Sabrina.Pagano@hcuge.ch.
Frank G PertonDepartment of Endocrinology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands. f.g.perton@umcg.nl.
Nicolas VuilleumierDivision of Laboratory Medicine, Department of Diagnostics, Hộpitaux Universitaires de Geneve, 1211 Geneva, Switzerland. Nicolas.Vuilleumier@hchuge.nl.
Hôpital Beau-Séjour · CHUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe determined relationships of cholesterol efflux capacity (CEC), plasma cholesterol esterification (EST) and cholesteryl ester transfer (CET) with anti-c-terminus apoA-1 (Ac-terAA1) and anti-apolipoprotein (apo)-1 (AAA1) autoantibodies in subjects with and without Type 2 diabetes mellitus (T2D).

methodsIn 75 T2D subjects and 75 nondiabetic subjects, Ac-terAA1 and AAA1 plasma levels were measured by enzyme-linked immunosorbent assay. CEC was measured as [³H]-cholesterol efflux from human cultured fibroblasts to diluted individual subject plasma. Plasma EST and CET were assayed by isotope methods.

resultsAc-terAA1 and AAA1 levels and were similar between T2D and control subjects. Univariate regression analysis (

conclusionsCEC, plasma EST and CET are inversely associated with Ac-terAA1 autoantibodies, conceivably attributable to an inverse relationship of these autoantibodies with apolipoprotein B-containing lipoproteins.

Indexed as

Antibodies, MonoclonalApolipoprotein A-IBiological TransportBiomarkersCase-Control StudiesCholesterolCholesterol, HDLDiabetes Mellitus, Type 2FemaleHumansLipid MetabolismMaleProtein Interaction Domains and MotifsAntibodies, MonoclonalApolipoprotein A-IBiomarkersCholesterolCholesterol, HDLanti-apoA-1 autoantibodiescholesterol efflux capacitycholesterol esterificationcholesteryl ester transferhigh-density lipoproteinsType 2 diabetes mellitus

Identifiers

PMID30744100
PMCPMC6387386
OpenAlexW2914712711

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.